Cargando…
Data for GAW20: genome-wide DNA sequence variation and epigenome-wide DNA methylation before and after fenofibrate treatment in a family study of metabolic phenotypes
GAW20 provided participants with an opportunity to comprehensively examine genetic and epigenetic variation among related individuals in the context of drug treatment response. GAW20 used data from 188 families (N = 1105) participating in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)...
Autores principales: | Aslibekyan, Stella, Almasy, Laura, Province, Michael A., Absher, Devin M., Arnett, Donna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157153/ https://www.ncbi.nlm.nih.gov/pubmed/30275886 http://dx.doi.org/10.1186/s12919-018-0114-0 |
Ejemplares similares
-
GAW20: methods and strategies for the new frontiers of epigenetics and pharmacogenomics
por: Tintle, Nathan L., et al.
Publicado: (2018) -
Methods for detecting methylation by SNP interaction in GAW20 simulation
por: Daw, E. Warwick, et al.
Publicado: (2018) -
Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015) -
Epigenome wide association study of SNP–CpG interactions on changes in triglyceride levels after pharmaceutical intervention: a GAW20 analysis
por: Veenstra, Jenna, et al.
Publicado: (2018) -
The challenge of detecting genotype-by-methylation interaction: GAW20
por: de Andrade, Mariza, et al.
Publicado: (2018)